Diabetes impairs adipose tissue-derived stem cell function and efficiency in promoting wound healing

Wound Repair and Regeneration

Volumn 21, Issue 4, 2013, Pages 545-553

  Cianfarani, Francesca ^a   Toietta, Gabriele ^a,b   Di Rocco, Giuliana ^b,c   Cesareo, Eleonora ^a   Zambruno, Giovanna ^a   Odorisio, Teresa ^a  

^a LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^b REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^c CENTRO CARDIOLOGICO MONZINO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

SCATTER FACTOR; SOMATOMEDIN C; VASCULOTROPIN;

ADIPOSE DERIVED STEM CELL; ALLOGENEIC STEM CELL TRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; FIBROBLAST; KERATINOCYTE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STREPTOZOCIN DIABETES; WOUND CLOSURE; WOUND HEALING;

ADIPOSE TISSUE; ANIMALS; CELL MOVEMENT; CELL PROLIFERATION; DIABETES MELLITUS, EXPERIMENTAL; FIBROBLASTS; HEPATOCYTE GROWTH FACTOR; INSULIN-LIKE GROWTH FACTOR I; KERATINOCYTES; MALE; MICE; STEM CELLS; STROMAL CELLS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; WOUND HEALING;

EID: 84879787911     PISSN: 10671927     EISSN: 1524475X     Source Type: Journal    
DOI: 10.1111/wrr.12051     Document Type: Article

References (41)

1. Boulton AJM, Vileikyte L, Ragnarson-Tennvall G, Apelqvist J,. The global burden of diabetic foot disease. Lancet 2005; 366: 1719-1724.
2. Wild S, Roglic G, Green A, Sicree R, King H,. Global prevalence of diabetes. Estimates for the year 2000 and projection for 2030. Diabetes Care 2004; 27: 1047-1053.
3. Jeffcoate WJ, Lipsky BA, Berendt AR, Cavanagh PR, Bus SA, Peters EJG, et al. on behalf of the three systematic review working parties of the International Working Group on the Diabetic Foot. Unresolved issues in the management of ulcers of the foot in diabetes. Diabet Med 2008; 25: 1380-1389.
4. Blumberg SN, Berger A, Hwang L, Pastar I, Warren SM, Chen W,. The role of stem cells in the treatment of diabetic foot ulcers. Diabetes Res Clin Pract 2012; 96: 1-9.
5. Tobita M, Orbay H, Mizuno H,. Adipose-derived stem cells: current findings and future perspectives. Discov Med 2011; 11: 160-170.
6. Kern S, Eichler H, Stroeve J, Kluter H, Bieback K,. Comparative analysis of mesenchymal stem cells from human bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 2006; 24: 1294-1301.
7. Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, Mizuno H, et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 2002; 13: 4279-4295.
8. Schäffler A, Büchler C,. Concise review: adipose tissue-derived stromal cells-basic and clinical implications for novel cell-based therapies. Stem Cells 2007; 25: 818-827.
9. Wilson A, Butler PE, Seifalian AM,. Adipose-derived stem cells for clinical applications: a review. Cell Prolif 2011; 44: 86-98.
10. Amos PJ, Kapur SK, Stapor PC, Shang H, Bekiranov S, Khurgel M, et al. Human adipose-derived stromal cells accelerate diabetic wound healing: impact of cell formulation and delivery. Tissue Eng Part A 2010; 16: 1595-1606.
11. Di Rocco G, Gentile A, Antonini A, Ceradini F, Wu JC, Capogrossi MC, et al. Enhanced healing of diabetic wounds by topical administration of adipose tissue-derived stromal cells overexpressing stromal-derived factor-1: biodistribution and engraftment analysis by bioluminescent imaging. Stem Cells Int 2011; 304562.
12. El-fetsi S, Chang EI, Longaker MT, Gurtner GC,. Aging and diabetes impair the neovascular potential of adipose-derived stromal cells. Plast Reconstr Surg 2009; 123: 475-485.
13. Nambu M, Kishimoto S, Nakamura S, Mizuno H, Yanagibayashi S, Yamamoto N, et al. Accelerated wound healing in healing-impaired db/db mice by autologous adipose tissue-derived stromal cells combined with atelocollagen matrix. Ann Plast Surg 2009; 62: 317-321.
14. Nie C, Yang D, Xu J, Si Z, Jin X, Zhang J,. Locally administered adipose-derived stem cells accelerate wound healing through differentiation and vasculogenesis. Cell Transplant 2011; 20: 205-216.
15. Ebrahimian TG, Pouzoulet C, Squiban C, Buard V, André M, Cousin B, et al. Cell therapy based on adipose tissue-derived stromal cells promotes physiological and pathological wound healing. Arterioscler Thromb Vasc Biol 2009; 29: 503-510.
16. Fiorina P, Pietramaggiori G, Scherer SS, Jurewicz M, Mathews JC, Vergani A, et al. The mobilization and effect of endogenous bone marrow progenitor cells in diabetic wound healing. Cell Transplant 2010; 19: 1369-1381.
17. Jin P, Zhang X, Wu Y, Li L, Yin Q, Zheng L, et al. Streptozotocin-induced diabetic rat-derived bone marrow mesenchymal stem cells have impaired abilities in proliferation, paracrine, antiapoptosis, and myogenic differentiation. Transplant Proc 2010; 42: 2745-2752.
18. Kanna S, Biswas S, Shang Y, Collard E, Azad A, Kauch C, et al. Macrophage dysfunction impairs resolution of inflammation in the wounds of diabetic mice. PLoS ONE 2010; 5: e9539.
19. Lerman OZ, Galiano RD, Armour M, Levine JP, Gurtner GC,. Cellular dysfunction in the diabetic fibroblast: impairment in migration, vascular endothelial growth factor production, and response to hypoxia. Am J Pathol 2003; 162: 303-312.
20. Tepper OM, Galiano RD, Capla JM, Kalka C, Cagne PJ, Jacobowitz GR, et al. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 2002; 26: 2781-2786.
21. Terashi H, Izumi K, Deveci M, Rhodes LM, Marcelo CL,. High glucose inhibits human epidermal keratinocyte proliferation for cellular studies on diabetes mellitus. Int Wound J 2005; 2: 298-304.
22. Kim HK, Kim YJ, Kim JT, Kwon CH, Kim YK, Bae YC, et al. Alterations in the proangiogenic functions of adipose tissue-derived stromal cells isolated from diabetic rats. Stem Cells Dev 2008; 17: 669-680.
23. Cramer C, Freisinger E, Jones RK, Slakey DP, Dupin CL, Newsome ER, et al. Persistent high glucose concentrations alter the regenerative potential of mesenchymal stem cells. Stem Cells Dev 2010; 19: 1875-1884.
24. Zambruno G, Marchisio P, Marconi A, Vaschieri C, Melchiori A, Giannetti A, et al. Transforming growth factor-beta 1 modulates beta 1 and beta 5 integrin receptors and induces the de novo expression of the alpha v beta 6 heterodimer in normal human keratinocytes: implications for wound healing. J Cell Biol 1995; 129: 853-865.
25. Coe LM, Zhang J, McCabe LR,. Both spontaneous Ins2(+/-) and streptozotocin-induced type I diabetes cause bone loss in young mice. J Cell Physiol 2013; 228: 689-695.
26. Gimble JM, Katz AJ, Bunnel BA,. Adipose-derived stem cells for regenerative medicine. Circ Res 2007; 100: 1249-1260.
27. Puissant B, Barreau C, Bourin P, Clavel C, Corre J, Bousquet C, et al. Immunomodulatory effect of human adipose tissue-derived adult stem cells: comparison with bone marrow mesenchymal stem cells. Br J Haematol 2005; 129: 118-129.
28. Taha MF, Hedayati V,. Isolation, identification and multipotential differentiation of mouse adipose tissue-derived stem cells. Tissue Cell 2010; 42: 211-216.
29. Chen L, Tredget EE, Wu PYG, Wu Y,. Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. PLoS ONE 2008; 3: e1886.
30. Kim WS, Park BS, Sung JH, Yang JM, Park SB, Kwok SJ, et al. Wound healing effect of adipose-derived stem cells: a critical role of secretory factors on human dermal fibroblasts. J Dermatol Sci 2007; 48: 15-24.
31. Moon KM, Park YH, Lee JS, Chae YB, Kim MM, Kim DS, et al. The effect of secretory factors of adipose-derived stem cells on human keratinocytes. Int J Mol Sci 2012; 13: 1239-1257.
32. Rehman J, Traktuev D, Li J, Merfeld-Clauss S, Temm-Grove CJ, Bovenkerk JE, et al. Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation 2004; 109: 1292-1298.
33. Werner S, Grose R,. Regulation of wound healing by growth factors and cytokines. Physiol Rev 2003; 83: 835-870.
34. Wagner W, Horn P, Castoldi M, Diehlmann A, Bork S, Saffrich R, et al. Replicative senescence of mesenchymal stem cells: a continuous and organized process. PLoS ONE 2008; 3: e2213.
35. Blogowski W, Ratajczak MZ, Zyzniewska-Banaszak E, Dolȩgowska B, Starzyńska T,. Adipose tissue as a potential source of hematopoietic stem/progenitor cells. Obesity 2012; 20: 923-931.
36. Fujimiya M, Nagaishi K, Yamashita T, Ataka K,. Bone marrow stem cell abnormality and diabetic complications. Anat Rec 2012; 295: 917-921.
37. Antazena MA, Sullivan SR, Usui ML, Gibran NS, Spenny ML, Larsen JA, et al. Neutral endopeptidase activity is increased in the skin of subjects with diabetic ulcers. J Invest Dermatol 2002; 119: 1400-1404.
38. Lobmann R, Schultz G, Lehnert H,. Proteases and the diabetic foot syndrome: mechanisms and therapeutic implications. Diabetes Care 2005; 28: 461-471.
39. Heo SC, Jeon ES, Lee IS, Kim MB, Kim JH,. Tumor necrosis factor-α-activated human adipose tissue-derived mesenchymal stem cells accelerate cutaneous wound healing through paracrine mechanisms. J Invest Dermatol 2011; 131: 1559-1567.
40. Yaňez R, Lamana ML, García-Castro J, Colmenero I, Ramírez M, Bueren JA,. Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease. Stem Cells 2006; 24: 2582-2591.
41. Chen L, Tredget EE, Liu C, Wu Y,. Analysis of allogenicity of mesenchymal stem cells in engraftment and wound healing in mice. PLoS ONE 2009; 4: e7119.